263 related articles for article (PubMed ID: 22949168)
1. The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines.
Lucero CM; Vega OA; Osorio MM; Tapia JC; Antonelli M; Stein GS; van Wijnen AJ; Galindo MA
J Cell Physiol; 2013 Apr; 228(4):714-23. PubMed ID: 22949168
[TBL] [Abstract][Full Text] [Related]
2. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
[TBL] [Abstract][Full Text] [Related]
3. Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells.
San Martin IA; Varela N; Gaete M; Villegas K; Osorio M; Tapia JC; Antonelli M; Mancilla EE; Pereira BP; Nathan SS; Lian JB; Stein JL; Stein GS; van Wijnen AJ; Galindo M
J Cell Physiol; 2009 Dec; 221(3):560-71. PubMed ID: 19739101
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2.
Zhang C; Long F; Wan J; Hu Y; He H
Oncol Rep; 2016 Jun; 35(6):3275-84. PubMed ID: 27035764
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
van der Deen M; Taipaleenmäki H; Zhang Y; Teplyuk NM; Gupta A; Cinghu S; Shogren K; Maran A; Yaszemski MJ; Ling L; Cool SM; Leong DT; Dierkes C; Zustin J; Salto-Tellez M; Ito Y; Bae SC; Zielenska M; Squire JA; Lian JB; Stein JL; Zambetti GP; Jones SN; Galindo M; Hesse E; Stein GS; van Wijnen AJ
J Biol Chem; 2013 Jul; 288(29):21307-21319. PubMed ID: 23720736
[TBL] [Abstract][Full Text] [Related]
6. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma.
Thomas DM; Johnson SA; Sims NA; Trivett MK; Slavin JL; Rubin BP; Waring P; McArthur GA; Walkley CR; Holloway AJ; Diyagama D; Grim JE; Clurman BE; Bowtell DD; Lee JS; Gutierrez GM; Piscopo DM; Carty SA; Hinds PW
J Cell Biol; 2004 Dec; 167(5):925-34. PubMed ID: 15583032
[TBL] [Abstract][Full Text] [Related]
7. Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.
Kurek KC; Del Mare S; Salah Z; Abdeen S; Sadiq H; Lee SH; Gaudio E; Zanesi N; Jones KB; DeYoung B; Amir G; Gebhardt M; Warman M; Stein GS; Stein JL; Lian JB; Aqeilan RI
Cancer Res; 2010 Jul; 70(13):5577-86. PubMed ID: 20530675
[TBL] [Abstract][Full Text] [Related]
8. The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts.
Galindo M; Pratap J; Young DW; Hovhannisyan H; Im HJ; Choi JY; Lian JB; Stein JL; Stein GS; van Wijnen AJ
J Biol Chem; 2005 May; 280(21):20274-85. PubMed ID: 15781466
[TBL] [Abstract][Full Text] [Related]
9. Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).
Pereira BP; Zhou Y; Gupta A; Leong DT; Aung KZ; Ling L; Pho RW; Galindo M; Salto-Tellez M; Stein GS; Cool SM; van Wijnen AJ; Nathan SS
J Cell Physiol; 2009 Dec; 221(3):778-88. PubMed ID: 19746444
[TBL] [Abstract][Full Text] [Related]
10. Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility.
van der Deen M; Akech J; Lapointe D; Gupta S; Young DW; Montecino MA; Galindo M; Lian JB; Stein JL; Stein GS; van Wijnen AJ
J Biol Chem; 2012 Feb; 287(7):4503-17. PubMed ID: 22158627
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
Jia F; Zhang Z; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
[TBL] [Abstract][Full Text] [Related]
12. RUNX2 and Osteosarcoma.
Li N; Luo D; Hu X; Luo W; Lei G; Wang Q; Zhu T; Gu J; Lu Y; Zheng Q
Anticancer Agents Med Chem; 2015; 15(7):881-7. PubMed ID: 25738872
[TBL] [Abstract][Full Text] [Related]
13. MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2.
Xie Y; Sun W; Deng Z; Zhu X; Hu C; Cai L
Sci Rep; 2017 Oct; 7(1):13388. PubMed ID: 29042587
[TBL] [Abstract][Full Text] [Related]
14. RUNX2 expression in developing human bones and various bone tumors.
Sugawara M; Kato N; Tsuchiya T; Motoyama T
Pathol Int; 2011 Oct; 61(10):565-71. PubMed ID: 21951664
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
[TBL] [Abstract][Full Text] [Related]
16. The cancer-related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis.
Villanueva F; Araya H; Briceño P; Varela N; Stevenson A; Jerez S; Tempio F; Chnaiderman J; Perez C; Villarroel M; Concha E; Khani F; Thaler R; Salazar-Onfray F; Stein GS; van Wijnen AJ; Galindo M
J Cell Physiol; 2019 Aug; 234(8):13659-13679. PubMed ID: 30637720
[TBL] [Abstract][Full Text] [Related]
17. Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?
Kendal JK; Singla A; Affan A; Hildebrand K; Al-Ani A; Ungrin M; Mahoney DJ; Itani D; Jirik FR; Monument MJ
Clin Orthop Relat Res; 2020 Dec; 478(12):2921-2933. PubMed ID: 33275394
[TBL] [Abstract][Full Text] [Related]
18. [MicroRNA-150 inhibits osteosarcoma cell proliferation by targeting RUNX2 gene].
Wang L; Wang W; Li J; Chen S; Zhan R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 41(12):1285-1290. PubMed ID: 28070040
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D Impacts the Expression of Runx2 Target Genes and Modulates Inflammation, Oxidative Stress and Membrane Vesicle Biogenesis Gene Networks in 143B Osteosarcoma Cells.
Garimella R; Tadikonda P; Tawfik O; Gunewardena S; Rowe P; Van Veldhuizen P
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28300755
[TBL] [Abstract][Full Text] [Related]
20. Developmental pathways hijacked by osteosarcoma.
Mortus JR; Zhang Y; Hughes DP
Adv Exp Med Biol; 2014; 804():93-118. PubMed ID: 24924170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]